Related Experiment Video
Updated: May 9, 2025

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
MTMR regulates KRAS function by controlling plasma membrane levels of phospholipids
Taylor E Lange1, Ali Naji2, Ransome van der Hoeven2
1Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
Abstract:
KRAS, a small GTPase involved in cell proliferation and differentiation, frequently gains activating mutations in human cancers. For KRAS to function, it must bind the plasma membrane (PM) via interactions between its membrane anchor and phosphatidylserine (PtdSer). Therefore, depleting PM PtdSer abrogates KRAS PM binding and activity. From a genome-wide siRNA screen to identify genes regulating KRAS PM localization, we identified a set of phosphatidylinositol (PI) 3-phosphatases: myotubularin-related proteins (MTMR) 2, 3, 4, and 7. Here, we show that silencing MTMR 2/3/4/7 disrupts KRAS PM interactions by reducing PM PI 4-phosphate (PI4P) levels, thereby disrupting the localization and operation of ORP5, a lipid transfer protein maintaining PM PtdSer enrichment. Concomitantly, silencing MTMR 2/3/4/7 elevates PM PI3P levels while reducing PM and total PtdSer levels. We also observed MTMR 2/3/4/7 expression is interdependent. We propose that the PI 3-phosphatase activity of MTMR is required for generating PM PI, necessary for PM PI4P synthesis, promoting the PM localization of PtdSer and KRAS.
Insights
Myotubularin-related proteins (MTMR) 2, 3, 4, and 7 regulate KRAS protein localization by controlling plasma membrane lipid levels. Their depletion disrupts KRAS binding, impacting cancer cell processes.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- KRAS, a key GTPase in cell signaling, requires plasma membrane (PM) binding for its function.
- Phosphatidylserine (PtdSer) on the PM is crucial for KRAS membrane association and activity.
- Activating KRAS mutations are common in human cancers.
Purpose of the Study:
- To identify genes regulating KRAS PM localization.
- To elucidate the role of phosphatidylinositol (PI) 3-phosphatases in KRAS membrane targeting.
Main Methods:
- Genome-wide siRNA screen to identify regulators of KRAS PM localization.
- Analysis of lipid levels (PI4P, PI3P, PtdSer) at the PM.
- Assessment of KRAS PM binding and activity upon gene silencing.
Main Results:
- Silencing myotubularin-related proteins (MTMR) 2, 3, 4, and 7 reduced PM PI 4-phosphate (PI4P) levels.
- MTMR depletion disrupted the ORP5 lipid transfer protein, impairing PM PtdSer enrichment.
- MTMR silencing elevated PM PI 3-phosphate (PI3P) and decreased PM and total PtdSer levels, affecting KRAS PM localization.
Conclusions:
- The PI 3-phosphatase activity of MTMR proteins is essential for maintaining PM PI levels.
- This activity supports PM PI4P synthesis, crucial for ORP5 function and PtdSer localization.
- MTMR proteins are critical regulators of PtdSer and KRAS localization at the plasma membrane.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases
MAPK Signaling Cascades

